Impact of Amiloride-Hydrochlorthiazide Diuretic Against the Pathway of Uric Acid – VLDL and Peroxynitrite in Essential Hypertension
Abstract
Thiazides induce metabolic derangement in terms of hyperlipidemia, glucose intolerance, hyperuricemia and electrolytes imbalance. Co-amiloride-hydrochlorthiazide therapy favorably corrects the hypokalemia that is induced by thiazides alone. This study was aimed to identify the interactions between serum uric acid, very-low-density-lipoprotein (VLDL) and peroxynitrite in essential hypertensive patients using amiloride-hydrochlorthiazide as antihypertensive therapy. A total number of fifty patients (12 males and 38 females) with a history of hypertension were admitted in the study. The patients were equally grouped to hypertensive patients treated with mono-therapeutic antihypertensive (Group I) agent other than amiloride-hydrochlorthiazide and hypertensive patients treated with mono-therapeutic antihypertensive: amiloride-hydrochlorthiazide (5/50 mg). Fasting peripheral venous blood was obtained for determination of fasting serum glucose, uric acid, lipid profile (total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol-cholesterol (HDL-c) and serum peroxynitrite. There were non-significant differences in characteristics, anthropometric and blood pressure measurements between groups. The metabolic profile and serum peroxynitrite were higher in Group II compared with corresponding Group I and reached significant level (p <0.01) with serum uric acid (5.41±1.0 mg/dL versus 4.7±0.64 mg/dL respectively). Significant correlation between serum uric acid and VLDL-cholesterol (VLDL-c) was observed in Group I (r=0.612, p <0.01) and Group II (r=0.0.547, p <0.01). Amiloride-hydrochlorthiazide as antihypertensive agent induces unfavorable metabolic derangement in hypertensive patients and may affect the health of patients.
Keywords: Amiloride-hydrochlorthiazide, metabolic derangement, hypertension
Cite this Article
Ansam Naji Al-Hasani, Omeed Jaleel Daloe. Impact of Amiloride-Hydrochlorthiazide Diuretic against The Pathway of Uric Acid VLDL and Peroxynitrite in Essential Hypertension. Research & Reviews: Journal of Pharmacology. 2015; 5(3): 6–11p
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
